Information  X 
Enter a valid email address

Union Jack Oil PLC (UJO)


Friday 17 September, 2021

Union Jack Oil PLC

Response to Market Speculation

RNS Number : 2125M
Union Jack Oil PLC
17 September 2021

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

17 September 2021

Union Jack Oil plc

("Union Jack" or the "Company")

Response to Market Speculation

Union Jack Oil plc (AIM: UJO), a UK focused onshore conventional hydrocarbon production, development and exploration company, notes recent market speculation and confirms that it is considering a potential equity fundraising to assist principally the funding of the proposed purchase of a further 25% interest in the Claymore Piper Complex Royalty Units as disclosed in the Interim Results released on Monday 13 September 2021, to upgrade certain producing assets to enhance cashflow and to progress the Company's other appraisal projects.

There is no certainty that the potential fundraising will proceed. A further announcement will be made in due course.


For further information, please contact:

Union Jack Oil plc

+44 (0)7801 540 358

David Bramhill

SP Angel Corporate Finance LLP

+44 (0)20 3470 0470

Nominated Adviser and Broker

Richard Morrison

Richard Hail

Caroline Rowe


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t